Ontology highlight
ABSTRACT: Background
New, effective treatments have resulted in long-term survival for small subgroups of metastatic non-small cell lung cancer (NSCLC) patients. However, knowledge of long-term survivor frequency and characteristics prior to modern therapies is lacking.Methods
Surveillance Epidemiology and End Results (SEER) patients with stage IV NSCLC diagnosed from 1991 to 2007 and followed through 2012 were dichotomized by survival time into the 10% who lived 21 months or longer (long-term survivors) vs the remaining 90% and compared with participants in a representative clinical trial of molecular profiling and targeted therapies (CUSTOM).Results
Among the 44 387 SEER patients, the 10% identified as long-term survivors were distinguishable from the remaining 90% by young
SUBMITTER: Davis JS
PROVIDER: S-EPMC6563418 | biostudies-literature | 2019 Jun
REPOSITORIES: biostudies-literature